Amelanotic melanoma and cherry angioma are two skin lesions that can look strikingly alike to the naked eye, yet one is a harmless collection of blood vessels and the other is a potentially deadly cancer. Both can appear as small, dome-shaped, reddish or pinkish bumps on the skin, which is exactly why the distinction matters so much. Amelanotic melanomas lack the dark pigment most people associate with skin cancer, and their misdiagnosis rate can reach as high as 89 percent because they mimic benign lesions so convincingly.1PubMed Central. Amelanotic nodular melanoma misdiagnosed as a benign skin lesion: A rare case report from Syria Understanding how these two spots differ, and when a red bump deserves a closer look, could genuinely save a life.
What Cherry Angiomas Actually Are
Cherry angiomas are the most common vascular growths on adult skin. They are benign clusters of tiny blood vessels (capillaries) that form a small, bright red to dark red dome, usually between one and five millimeters across. They are sometimes called Campbell de Morgan spots, and they tend to appear on the trunk, upper arms, and thighs. Almost everyone develops at least a few as they age. A large population study found that their number and size increase with age, that men tend to develop more than women, and that fair-skinned individuals of Caucasian ancestry are particularly prone to them.2Dermatology. Anatomic Distribution of Cherry Angiomas in the General Population
Cherry angiomas are entirely harmless. They do not become cancerous. They do not spread. They do not need treatment unless they bleed from trauma or you dislike how they look. Their only real medical significance is that they sit in the same visual neighborhood as other red lesions on the skin, some of which are not harmless at all.
What Makes Amelanotic Melanoma So Deceptive
Melanoma is skin cancer that arises from melanocytes, the cells that produce the brown pigment melanin. Most melanomas are dark brown or black because the cancerous melanocytes are still churning out melanin. Amelanotic melanomas, however, produce little to no melanin, so they show up as pink, red, or skin-colored bumps instead. In one large database review, red amelanotic melanomas accounted for about 4 percent of all melanomas and made up roughly 70 percent of all amelanotic melanomas.3PubMed Central. Amelanotic Melanomas Presenting as Red Skin Lesions: A Diagnostic Challenge with Potentially Lethal Consequences In other words, the overwhelming majority of amelanotic melanomas are red, not pale or flesh-toned as some people expect.
Because they lack the classic dark color, amelanotic melanomas do not trigger the warning signs most people have been taught to look for. The standard ABCD checklist (asymmetry, border irregularity, color variation, diameter over 6 mm) was designed with pigmented melanoma in mind. Thick, life-threatening melanomas can lack all of these classical features, which means relying on the ABCD rule alone can miss the most dangerous cases.4PubMed. Clinical practice guidelines for the diagnosis and management of melanoma: melanomas that lack classical clinical features That disconnect between what people expect melanoma to look like and what amelanotic melanoma actually looks like is where the confusion with cherry angiomas begins.
How They Look Different Under Careful Observation
To the untrained eye, a small amelanotic melanoma and a cherry angioma can be nearly indistinguishable. Both can be a few millimeters wide, reddish, and slightly raised. But there are clues that separate them, even before a dermatoscope comes out.
Cherry angiomas tend to be well-defined, round, and uniformly colored. They usually have a smooth, dome-shaped surface. They appear gradually, stay stable in size (or grow very slowly over years), and blend in with the dozens of other cherry angiomas on your body. If you press on one, it may blanch slightly, because the redness comes from blood-filled capillary spaces.
Amelanotic melanomas, by contrast, are more likely to be irregularly shaped or asymmetric. Their surface can be uneven, sometimes with a subtle scaly crust or a small area of erosion. The color may not be uniformly red: there can be pale whitish zones, subtle brown or blue-gray specks hiding at the edges, or a pinkish-white halo. Most critically, an amelanotic melanoma tends to change. It grows, evolves in shape, or develops new features over weeks to months. A cherry angioma that has sat quietly on your chest for two years is almost certainly just that. A new pink bump that appeared recently and seems to be getting bigger is the one that warrants attention.
What Dermoscopy Reveals
A dermatoscope is a handheld magnifying tool with built-in lighting that lets clinicians see structures in the skin invisible to the naked eye. It is the frontline technology for telling ambiguous red lesions apart, and the differences between cherry angiomas and amelanotic melanomas become much more apparent under magnification.
Cherry angiomas typically show a pattern called lacunae: round or oval, well-demarcated pockets of reddish-brown to reddish-blue color that look like small lagoons of blood. The vessels within them tend to be orderly. A dermoscopy study of vascular anomalies described the vascular morphology of cherry angiomas as including serpentine, coiled, looped, and curved vessels, with some lesions appearing darker or showing a faint white veil on the surface.5PubMed Central. Dermoscopic Features Summarization and Comparison of Four Types of Cutaneous Vascular Anomalies The key feature is that the vascular pattern is fairly consistent and organized throughout the lesion.
Amelanotic melanomas look quite different through a dermatoscope. Instead of orderly lacunae, they show what is called vascular polymorphism: a chaotic mix of different vessel types within the same lesion. You might see dotted vessels next to linear irregular vessels next to looped vessels, all jumbled together. Under polarized light, amelanotic melanomas can also show milky-red areas (a diffuse pinkish-red background glow), chrysalis structures (white shiny streaks visible only in polarized mode), and scattered blue-gray dots that hint at residual melanin deeper in the skin.6PubMed Central. Dermoscopic clues in the diagnosis of amelanotic and hypomelanotic malignant melanoma Aggressive amelanotic melanomas can be mistaken for vascular lesions even on dermoscopy, but the combination of vessel chaos and those milky-red zones is a strong red flag that the lesion is not a simple blood-vessel growth.7Academia.edu. Dermatoscopy of Vascular Lesions
Diagnostic Algorithms for Pink and Red Bumps
Because amelanotic lesions break the rules of traditional melanoma screening, dermatologists have developed specific stepwise approaches for evaluating non-pigmented (pink, red, or skin-colored) bumps. These algorithms rely heavily on the vessel patterns and surface features visible through a dermatoscope, rather than on the color cues used for pigmented lesions.
One published method starts by checking for ulceration, then for “white clues” (white lines, white structureless areas, or keratin-related features on the surface). If neither of those is present, the clinician moves to detailed vessel pattern analysis, looking at whether the vessels are polymorphous (multiple vessel types mixed together, a suspicious sign) or monomorphous (one vessel type, which is more reassuring).8PubMed Central. Prediction without Pigment: a decision algorithm for non-pigmented skin malignancy
A newer approach, described as the “Two-Step-7-Pink Rule,” divides features into suspicious criteria and non-suspicious criteria. Suspicious features include polymorphous or sharply focused vessels, scales or crusts, and erosions or ulcerations. Non-suspicious features include a white collarette (a ring of peeling skin around the base, typical of certain benign growths), white scar-like areas, vascular lacunae (the hallmark of cherry angiomas), and “necklace” pinpoint vessels arranged in a ring pattern.9PubMed Central. Two-step-7-Pink Rule: A Practical Tool for the Dermoscopic Evaluation of Fully Amelanotic Skin Lesions The presence of vascular lacunae specifically points toward a benign vascular lesion like a cherry angioma, while a mix of vessel chaos, crusting, and erosion pushes the diagnosis toward something that needs a biopsy.
When Dermoscopy Is Not Enough
Even experienced dermatologists using dermatoscopes can face genuinely difficult calls. Some amelanotic melanomas produce just enough residual pigment or have just enough organized vasculature to pass as benign. For flat pink lesions in particular, adding a technology called reflectance confocal microscopy to the workup improves accuracy. This tool lets clinicians see skin structures at near-cellular resolution without cutting into the skin. A study comparing the two approaches found that combining dermoscopy with confocal microscopy raised sensitivity for amelanotic melanoma to roughly 91 percent, compared to about 85 percent for dermoscopy alone.10PubMed Central. Dermoscopy and reflectance confocal microscopy of solitary flat pink lesions: A new combined score to diagnose amelanotic melanoma In confocal imaging, features like disorganized patterns in the skin’s outer layer and atypical cells migrating upward through the epidermis are strong indicators of melanoma, while an orderly skin architecture points away from cancer.
When imaging still leaves doubt, the definitive answer comes from a biopsy. A small sample of skin tissue is removed and examined under a microscope, where the cellular architecture tells the story clearly. Cherry angiomas reveal clusters of benign dilated capillaries in the upper skin layer, with no abnormal cell growth. Melanoma reveals atypical melanocytes invading the tissue.
Tricky Cases in the Pathology Lab
Even under a microscope, amelanotic melanoma can be a diagnostic puzzle. Pathologists often use a panel of protein stains (immunohistochemistry) to confirm that a tumor is melanocytic in origin. The protein S-100, for example, is a classic marker for melanoma. But in rare cases, melanomas can be completely negative for S-100, which means relying on a single stain could lead to a missed diagnosis. When that happens, additional markers are needed to confirm the melanocytic lineage of the tumor.11PubMed Central. A case of S-100 negative melanoma: A diagnostic pitfall in the workup of a poorly differentiated metastatic tumor of unknown origin One such marker is SOX10, a transcription factor involved in melanocyte development that has been shown to be a sensitive marker of melanoma, including subtypes that other stains can miss.12Applied Immunohistochemistry & Molecular Morphology. SOX10 Expression in Malignant Melanoma, Carcinoma, and Normal Tissues
None of this applies to cherry angiomas, which are made up of blood vessel cells, not melanocytes. The two lesions have completely different cell types under the microscope. The challenge is not confusion between the two at the tissue level; it is getting the correct lesion biopsied in the first place.
Why a Growing Red Bump Should Never Be Lasered
One practical risk worth highlighting involves cosmetic treatment. Cherry angiomas are commonly removed with laser therapy, electrocautery, or cryotherapy for cosmetic reasons. If a red bump is assumed to be a cherry angioma and treated with a laser without a biopsy, and it turns out to be an amelanotic melanoma, the consequences can be severe. Laser treatment destroys the tissue, removing the opportunity to examine it under a microscope. More critically, it can delay a melanoma diagnosis, and that delay may affect outcomes. Research has shown that laser therapy of pigmented lesions can prevent appropriate and timely treatment of hidden melanomas and potentially lead to fatal outcomes.13PubMed. Melanoma after laser therapy of pigmented lesions–circumstances and outcome
The practical takeaway: if you have a red bump that is new, growing, bleeding without trauma, or looks different from your other cherry angiomas, have it evaluated before removing it. A dermatologist can examine it with dermoscopy in a quick office visit. If the dermoscopic picture is classic for a cherry angioma (lacunae, orderly vessels, no polymorphism), cosmetic removal is reasonable. If there is any doubt, a biopsy should come first.
Molecular Features of Amelanotic Melanoma
Amelanotic melanomas are not a biologically separate type of melanoma; they are melanomas that happen to produce very little pigment. Their underlying genetic mutations are similar to those of pigmented melanomas, which matters for treatment. A study examining 33 amelanotic melanomas found BRAF mutations in about 70 percent of cases, a figure that jumped to 89 percent among thin (early-stage) amelanotic melanomas. KIT mutations were found in about 12 percent of cases.14PubMed. BRAF and KIT somatic mutations are present in amelanotic melanoma Both BRAF and KIT are targets for drugs already available in melanoma treatment, so the fact that amelanotic melanomas carry these same mutations means patients with advanced disease have access to the same targeted therapies as those with pigmented melanomas.
Cherry angiomas, by contrast, have no malignant potential and no clinically relevant mutation profile. They are benign from every angle: clinical appearance, microscopic architecture, and molecular biology. The comparison between the two exists purely because they can look alike on the skin surface, not because they share any biological kinship.
Who Should Be Especially Vigilant
Certain groups face a higher risk of amelanotic melanoma or a greater chance of having one mistaken for something benign. Fair-skinned individuals, who are also the group most likely to accumulate many cherry angiomas, are at higher baseline risk of melanoma in general.15Dermatology. Anatomic Distribution of Cherry Angiomas in the General Population People who already have many cherry angiomas may develop a dangerous complacency toward new red bumps because they are so accustomed to seeing them. That familiarity can work against you if an amelanotic melanoma appears among a field of benign spots.
People with a personal or family history of melanoma should be particularly watchful. Immunosuppressed individuals, including organ transplant recipients and those on certain medications, face both an elevated skin cancer risk and a greater chance that melanomas will present with unusual features. Older adults on body sites with chronic sun damage are another group where amelanotic melanomas tend to appear, sometimes on the scalp, ears, or lower legs where they can be easily overlooked.
The Limits of Self-Checks
Regular skin self-exams are valuable, but for amelanotic lesions they have a genuine blind spot. You are looking for the ugly duckling: the one lesion that does not look like the others. If you have many cherry angiomas and one of them starts behaving differently (growing faster, becoming asymmetric, developing a crust), that is the one to flag. Change over time is the single most important clue for lesions that lack the usual melanoma warning colors. Australian clinical guidelines explicitly emphasize that a thorough history of change in morphology and growth over time is essential when classic visual features are absent.16PubMed. Clinical practice guidelines for the diagnosis and management of melanoma: melanomas that lack classical clinical features
Photographing your skin periodically can help. A photo from six months ago showing a smooth 3 mm red dot, compared to today’s 6 mm bumpy pink lesion with a scaly surface, is powerful evidence that something has changed. Many dermatology practices now offer total-body photography and sequential digital dermoscopy, where individual lesions are photographed through a dermatoscope over time and compared algorithmically for changes. This is especially useful for people with many moles or many vascular lesions, where manual comparison becomes unreliable.
When a Cherry Angioma Really Is Just a Cherry Angioma
It is worth stepping back from the alarm and noting that the overwhelming majority of small red bumps on your skin are exactly what they appear to be: benign cherry angiomas. Amelanotic melanoma is uncommon, accounting for a small fraction of an already uncommon cancer. The point of understanding the distinction is not to panic about every red dot but to know which ones deserve a second look. A longstanding, stable, symmetrical, dome-shaped red papule that looks identical to its neighbors is, statistically, almost certainly benign. It is the outlier that warrants attention: the new one, the changing one, the one that bleeds unprovoked, the one with an irregular border or mixed colors, the one that feels firm rather than soft. If you have a bump that fits any of those descriptions, a dermatologist’s evaluation with dermoscopy can resolve the question in minutes and, in the rare case that it turns out to be something more, can make all the difference in how the story ends.